PYXS Competitors & Alternatives
Compare Pyxis Oncology Inc with similar stocks in the same industry
Biotechnology
PYXS
Main Stock$1.63
Tradestie Score
53
Market Cap
$135.82M
Analyst Upside
+406.0%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NGNE
Neurogene, Inc. Common Stock
|
$25.42
|
$256.54M | - | 32 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.77
|
$240.89M | - | 41 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$5.06
|
$231.77M | - | 44 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$11.25
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.48
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.33
|
$202.58M | - | 34 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.58
|
$199.71M | - | 48 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.78
|
$154.27M | - | 48 | Compare |
More PYXS Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry